MSCs-laden injectable self-healing hydrogel for systemic sclerosis treatment

As a novel cellular therapy, the anti-inflammatory and immunomodulatory virtues of mesenchymal stem cells (MSCs) make them promising candidates for systemic sclerosis (SSc) treatment. However, the clinical efficacy of this stratagem is limited because of the short persistence time, poor survival, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Min, Kong, Bin, Chen, Guopu, Xie, Ying, Zhao, Yuanjin, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964965/
https://www.ncbi.nlm.nih.gov/pubmed/35386467
http://dx.doi.org/10.1016/j.bioactmat.2022.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964965/
https://www.ncbi.nlm.nih.gov/pubmed/35386467
http://dx.doi.org/10.1016/j.bioactmat.2022.01.006

Ejemplares similares